FDA’s Deceptive Drug Ad Focus Leaves Telehealth Sites Guessing

The Trump administration’s focus on pharmaceutical advertising has sparked questions about the FDA’s authority to regulate telehealth companies that use social media influencers to promote boutique versions of popular drugs.